Currently out of the existing stock ratings of Sung Ji Nam, 123 are a BUY (90.44%), 13 are a HOLD (9.56%).

Sung Ji Nam

Work Performance Price Targets & Ratings Chart

Analyst Sung Ji Nam, currently employed at SCOTIABANK, carries an average stock price target met ratio of 54.91% that have a potential upside of 24.51% achieved within 180 days. Previously, Sung Ji Nam worked at BTIG.

Sung Ji Nam’s has documented 260 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GH, Guardant Health at 31-Jul-2025.

Wall Street Analyst Sung Ji Nam

Analyst best performing recommendations are on GNMK (GENMARK DIAGNOSTICS).
The best stock recommendation documented was for VCYT (VERACYTE) at 11/4/2020. The price target of $42 was fulfilled within 1 day with a profit of $1.97 (4.92%) receiving and performance score of 49.21.

Average potential price target upside

of $73.87 (20.03%) on TMO (THERMO FISHER SCIENTIFIC).
of $34.87 (17.66%) on ILMN (ILLUMINA).
of $23.62 (49.85%) on EXAS (EXACT SCIENCES).

BDSX Biodesix BNGO Bionano Genomics CDNA Caredx CSTL Castle Biosciences FLDM Fluidigm FLGT Fulgent Genetics GTH Genetron Holdings Ltd ILMN Illumina LMNX Luminex TMO Thermo Fisher Scientific VCYT Veracyte BRKR Bruker DMTK DermTech QTRX Quanterix Corp OLK Olink Holding AB ADR TKNO Alpha Teknova ADPT Adaptive Biotechnologies Corp CNTG Centogene B V GH Guardant Health MYGN Myriad Genetics PACB Pacific Biosciences of California TWST Twist Bioscience Corp QTNT Quotient Ltd TECH Bio-Techne Corp WAT Waters LAB Standard Biotools GNMK GenMark Diagnostics DHR Danaher EXAS EXACT Sciences

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kyle Mikson (CANACCORD)